Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 38, Pages 10666-10671
Publisher
Proceedings of the National Academy of Sciences
Online
2016-09-07
DOI
10.1073/pnas.1611481113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein Kinase Inhibitor H89 Enhances the Activity of Pseudomonas Exotoxin A-Based Immunotoxins
- (2016) X. Liu et al. MOLECULAR CANCER THERAPEUTICS
- New Life for Immunotoxin Cancer Therapy
- (2015) R. Hassan et al. CLINICAL CANCER RESEARCH
- Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia
- (2015) Brunangelo Falini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor
- (2015) Sebastian Stahl et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro results
- (2015) Emily Mason-Osann et al. Scientific Reports
- Immunotoxins for leukemia
- (2014) A. S. Wayne et al. BLOOD
- In Vitro and In Vivo Activity of the Low-Immunogenic Antimesothelin Immunotoxin RG7787 in Pancreatic Cancer
- (2014) K. Hollevoet et al. MOLECULAR CANCER THERAPEUTICS
- Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers
- (2014) C. Alewine et al. MOLECULAR CANCER THERAPEUTICS
- p53-Based cyclotherapy: exploiting the ‘guardian of the genome’ to protect normal cells from cytotoxic therapy
- (2013) B Rao et al. BRITISH JOURNAL OF CANCER
- The Insulin Receptor Negatively Regulates the Action of Pseudomonas Toxin-Based Immunotoxins and Native Pseudomonas Toxin
- (2013) X. F. Liu et al. CANCER RESEARCH
- Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family
- (2013) K Azijli et al. CELL DEATH AND DIFFERENTIATION
- Diphtheria toxin-based targeted toxin therapy for brain tumors
- (2013) Yan Michael Li et al. JOURNAL OF NEURO-ONCOLOGY
- Targeting the Regulatory Machinery of BIM for Cancer Therapy
- (2012) Hisashi Harada et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Killing of Resistant Cancer Cells with Low Bak by a Combination of an Antimesothelin Immunotoxin and a TRAIL Receptor 2 Agonist Antibody
- (2011) Xing Du et al. CLINICAL CANCER RESEARCH
- A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer
- (2011) John E. Weldon et al. FEBS Journal
- Crosstalk in NF-κB signaling pathways
- (2011) Andrea Oeckinghaus et al. NATURE IMMUNOLOGY
- Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels
- (2010) Kaspar Burger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pseudomonas Exotoxin A-Mediated Apoptosis Is Bak Dependent and Preceded by the Degradation of Mcl-1
- (2010) X. Du et al. MOLECULAR AND CELLULAR BIOLOGY
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- Mesothelin targeted cancer immunotherapy
- (2007) Raffit Hassan et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now